Dr. Nur Kusaira is a dedicated plant biotechnology researcher with a deep passion for unlocking the therapeutic and nutritional potential of plant natural products. Her academic journey began with a Bachelor's degree in Plant Resource Science and Management from Universiti Malaysia Sarawak (UNIMAS) in 2008, majoring in Plant Systematics. She was awarded the Best Undergraduate Thesis that year.

She went on to earn a Master's in Healthcare Biotechnology from Universiti Sains Malaysia (USM), where she focused on in silico screening of phytocompounds against H5N1 and H1N1 influenza viruses under the supervision of Prof. Dr. Habibah Abd Wahab. In 2012, she undertook a research attachment at UC San Diego, where she conducted molecular dynamics simulations of plant-based inhibitors targeting the NS2B/NS3 protein of Dengue virus type 2 (DENV-2).

Her career then led her to Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), where she managed the USM-RIKEN natural product discovery grant, working on the development of a comprehensive library of Malaysian plant extracts intended for diverse bioactivity screenings, laying the groundwork for systematic exploration of Malaysia’s phytochemical biodiversity.

Though initially set to pursue her PhD at USM, Dr. Nur Kusaira was awarded an international PhD scholarship by Universiti Malaya and joined the University of Copenhagen, Denmark, under Prof. Dr Henrik Toft Simonsen. Her PhD work made headlines in plant synthetic biology, she pioneered the use of Physcomitrella patens for stable in vivo assembly of biosynthetic gene clusters, achieving the first stable plant-based production of artemisinin, a vital antimalarial drug, marking a breakthrough in sustainable pharmaceutical production.

Her research continues at the intersection of plant science, biotechnology, and health. She focuses on:

• Functional Food Innovation: Developing plant-based bioactives with nutraceutical properties for preventive health and wellness.
• Drug Discovery: Leveraging computational tools to identify potent, selective plant-based inhibitors targeting cancer, viral and microbial proteins.
• Plant Synthetic Biology: Exploring plant platforms like moss and medicinal species for scalable biosynthesis of valuable therapeutic molecules.

Dr. Nur Kusaira’s work reflects a commitment to sustainability, global health, and innovation paving the way for plant-derived therapeutics that are effective, affordable, and accessible worldwide.